Vote Set Next Week on House Drug Pricing Bill
Allows direct government price negotiations
The House has announced it will vote next week on Speaker Nancy Pelosi’s Lower Drug Costs Now Act, recently renamed to honor the late Maryland Representative Elijah Cummings.
Under the legislation, the government would be allowed to negotiate drug prices directly with pharmaceutical companies, with the hope being lowering prices of the most expensive medications, including insulin. Up to 200 pharmaceuticals are subject to the bill that would also penalize companies that refuse to come to the negotiating table.
“We have now received enough guidance from [the Congressional Budget Office] to bring the Lower Drug Costs Now Act to the Floor and to reinvest its savings in one of the most transformational improvements to Medicare since its creation,” Pelosi and other lawmakers said in a statement.
The pharmaceutical industry has called the bill radical. The measure is expected to die in the Senate in favor of other legislation more in line with President Trump’s plans.
- For members of the House of Representatives as they prepare to cast their votes on the bill designed to lower drug costs.
- About the extreme increases seen in recent months in drugs like insulin and many others needed for sustaining life.